TNF and juvenile idiopathic arthritis: TNF-α inhibitors (TNFis) have revolutionized the treatment of certain chronic immune-mediated diseases, being widely and successfully used in rheumatic inflammatory diseases such as AS, RA, PsA, and JIA [3,4].